Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors

被引:47
作者
Cheng, Ming-Fu [1 ]
Hung, Ming-Shiu [1 ]
Song, Jen-Shin [1 ]
Lin, Shu-Yu [1 ]
Liao, Fang-Yu [1 ]
Wu, Mine-Hsine [1 ]
Hsiao, Wenchi [1 ]
Hsieh, Chia-Ling [1 ]
Wu, Jian-Sung [1 ]
Chao, Yu-Sheng [1 ]
Shih, Chuan [1 ]
Wu, Su-Ying [1 ]
Ueng, Shau-Hua [1 ]
机构
[1] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan 35053, Miaoli County, Taiwan
关键词
Sulfonylhydrazide; Indoleamine 2,3-dioxygenase; Structure-activity relationship; Molecular docking; CANCER-IMMUNOTHERAPY; DERIVATIVES; INDOLEAMINE-2,3-DIOXYGENASE; BLOCKADE; TARGET; PD-1;
D O I
10.1016/j.bmcl.2014.05.084
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel class of phenyl benzenesulfonylhydrazides has been identified as potent inhibitors of indoleamine 2,3-dioxygenase (IDO), and their structure-activity relationship was explored. Coupling reactions between various benzenesulfonyl chlorides and phenylhydrazides were utilized to synthesize the sulfonylhydrazides bearing various substituents. Compound 3i exhibited 61 nM of IC50 in enzymatic assay and 172 nM of EC50 in the HeLa cell. The computational study of 3i suggested that the major interactions between 3i and IDO protein are the coordination of sulfone and heme iron, the hydrogen bonding and hydrophobic interactions between 3i and IDO. This novel class of IDO inhibitor provides a new direction to discover effective anti-cancer agents. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3403 / 3406
页数:4
相关论文
共 50 条
  • [31] Structure and Plasticity of Indoleamine 2,3-Dioxygenase 1 (IDO1)
    Roehrig, Ute F.
    Michielin, Olivier
    Zoete, Vincent
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (24) : 17690 - 17705
  • [32] Identification of potent virtual leads to design novel indoleamine 2,3-dioxygenase inhibitors: Pharmacophore modeling and molecular docking studies
    John, Shalini
    Thangapandian, Sundarapandian
    Sakkiah, Sugunadevi
    Lee, Keun Woo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) : 4004 - 4012
  • [33] Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation
    Xu, Xi
    Ren, Jie
    Ma, Yinghe
    Liu, Hongting
    Rong, Quanjin
    Feng, Yifan
    Wang, Yameng
    Cheng, Yu
    Ge, Ruijia
    Li, Zhiyu
    Bian, Jinlei
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 250 - 263
  • [34] Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry
    Coletti, Alice
    Greco, Francesco Antonio
    Dolciami, Daniela
    Camaioni, Emidio
    Sardella, Roccaldo
    Pallotta, Maria Teresa
    Volpi, Claudia
    Orabona, Ciriana
    Grohmann, Ursula
    Macchiarulo, Antonio
    MEDCHEMCOMM, 2017, 8 (07) : 1378 - 1392
  • [35] Discovery and biological evaluation of tanshinone derivatives as potent dual inhibitors of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase
    Liu, Jiangxin
    Ren, Jian
    Yang, Kun
    Chen, Shuang
    Yang, Xinni
    Zhao, Qin-Shi
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 235
  • [36] Influence of the presence of the heme cofactor on the JK-loop structure in indoleamine 2,3-dioxygenase 1
    Mirgaux, Manon
    Leherte, Laurence
    Wouters, Johan
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2020, 76 : 1211 - 1221
  • [37] Fused Heterocyclic Compounds as Potent Indoleamine-2,3-dioxygenase 1 Inhibitors
    Panda, Subhankar
    Roy, Ashalata
    Deka, Suman Jyoti
    Trivedi, Vishal
    Manna, Debasis
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (12): : 1167 - 1172
  • [38] Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
    Rohrig, Ute F.
    Majjigapu, Somi Reddy
    Reynaud, Aline
    Pojer, Florence
    Dilek, Nahzli
    Reichenbach, Patrick
    Ascencao, Kelly
    Irving, Melita
    Coukos, George
    Vogel, Pierre
    Michielin, Olivier
    Zoete, Vincent
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (04) : 2205 - 2227
  • [39] Effects of Various Phytochemicals on Indoleamine 2,3-Dioxygenase 1 Activity: Galanal Is a Novel, Competitive Inhibitor of the Enzyme
    Yamamoto, Rie
    Yamamoto, Yasuko
    Imai, Shinjiro
    Fukutomi, Ryuta
    Ozawa, Yoshio
    Abe, Masako
    Matuo, Yushi
    Saito, Kuniaki
    PLOS ONE, 2014, 9 (02):
  • [40] Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
    Brown, Zachary J.
    Yu, Su Jong
    Heinrich, Bernd
    Ma, Chi
    Fu, Qiong
    Sandhu, Milan
    Agdashian, David
    Zhang, Qianfei
    Korangy, Firouzeh
    Greten, Tim F.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (08) : 1305 - 1315